{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:00:38Z","timestamp":1791064838045,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ccl.2010.04.001","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T01:18:36Z","timestamp":1278897516000},"page":"517-527","source":"Crossref","is-referenced-by-count":67,"title":["The Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk"],"prefix":"10.1016","volume":"28","author":[{"given":"David A.","family":"Calhoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2010.04.001_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.HYP.0000252676.46043.18","article-title":"Prevalence, awareness, treatment, and control of hypertension among United States Adults 1999\u20132004","volume":"49","author":"Ong","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","article-title":"Incidence and precursors of hypertension in young adults: the Framingham Off-spring Study","volume":"16","author":"Garrison","year":"1987","journal-title":"Prev Med"},{"key":"10.1016\/j.ccl.2010.04.001_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.amjhyper.2003.12.012","article-title":"Susceptibility of the influence of weight on blood pressure in men versus women: lessons from a large-scale study of adults","volume":"17","author":"Sharabi","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ccl.2010.04.001_bib4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/00004872-199412000-00018","article-title":"Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey","volume":"12","author":"Jones","year":"1994","journal-title":"J Hypertens"},{"key":"10.1016\/j.ccl.2010.04.001_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.HYP.37.3.845","article-title":"Arterial pressure, left ventricular mass, and aldosterone in essential hypertension","volume":"37","author":"El-Gharbawy","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.HYP.0000154364.00763.d5","article-title":"Hyperaldosteronism and hypertension: ethnic differences","volume":"45","author":"Grim","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.109.129320","article-title":"Programming of hypertension: associations of plasma aldosterone in adult men and women with birthweight, cortisol, and blood pressure","volume":"53","author":"Reynolds","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinbereger","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ccl.2010.04.001_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trail volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ccl.2010.04.001_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ccl.2010.04.001_bib12","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2010.04.001_bib13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"High prevalence of primary aldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2010.04.001_bib15","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.ccl.2010.04.001_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"\u0160trauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ccl.2010.04.001_bib17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Resistant hypertension characterized by increased aldosterone levels and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2010.04.001_bib18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ccl.2010.04.001_bib19","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/sj.ki.5000378","article-title":"Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample","volume":"69","author":"Fox","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ccl.2010.04.001_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"PAPY Study Investigators. Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","article-title":"Plasma aldosterone is independently associated with the metabolic syndrome","volume":"48","author":"Bochud","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence of an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2010.04.001_bib23","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patient presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2010.04.001_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2010.04.001_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2010.04.001_bib26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2010.04.001_bib27","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/en.141.10.3871","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ccl.2010.04.001_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2009.05.006","article-title":"Mineralocorticoid receptors in the metabolic syndrome","volume":"20","author":"Zennaro","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ccl.2010.04.001_bib30","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M607741200","article-title":"Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9","volume":"282","author":"Yokota","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ccl.2010.04.001_bib31","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1681\/ASN.2004100828","article-title":"Aldosterone-induced serum and glucocorticoid-induced kinase 1 expression is accompanied by Nedd4-2 phosphorylation and increased Na+ transport in cortical collecting duct cells","volume":"16","author":"Flores","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2010.04.001_bib32","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1074\/jbc.M412884200","article-title":"14-3-3 proteins modulate the expression of epithelial Na+ channels by phosphorylation-dependent interaction with Nedd4-2 ubiquitin ligase","volume":"280","author":"Ichimura","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ccl.2010.04.001_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1254\/jphs.08R02CR","article-title":"Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury","volume":"108","author":"Kiyomoto","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.ccl.2010.04.001_bib34","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1046\/j.1523-1755.2001.0590051850.x","article-title":"Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats","volume":"59","author":"Ray","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.ccl.2010.04.001_bib35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/HYPERTENSIONAHA.109.135392","article-title":"Critical role of apoptosis signal-regulating kinase 1 in aldosterone\/salt-induced cardiac inflammation and fibrosis","volume":"54","author":"Nakamura","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib36","doi-asserted-by":"crossref","first-page":"F1381","DOI":"10.1152\/ajprenal.00101.2009","article-title":"Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions","volume":"297","author":"Lee","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ccl.2010.04.001_bib37","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.HYP.0000175814.18550.c0","article-title":"Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor","volume":"46","author":"Xue","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.2008040364","article-title":"Plasmin in nephrotic urine activates the epithelial sodium channel","volume":"20","author":"Svenningsen","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2010.04.001_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-9149(86)90845-3","article-title":"Role of aldosterone in blood pressure regulation of obese adolescents","volume":"57","author":"Rocchini","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2010.04.001_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","article-title":"Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women","volume":"7","author":"Goodfriend","year":"1999","journal-title":"Obes Res"},{"key":"10.1016\/j.ccl.2010.04.001_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0952-3278(99)80020-9","article-title":"Plasma aldosterone, plasma lipoproteins, obesity and insulin in humans","volume":"60","author":"Goodfriend","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.ccl.2010.04.001_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.ijo.0801483","article-title":"Insulin, renin-aldosterone system and blood pressure in obese people","volume":"25","author":"Andronico","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ccl.2010.04.001_bib43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ajh.2009.167","article-title":"Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans","volume":"22","author":"Kidambi","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ccl.2010.04.001_bib44","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ajh.2008.225","article-title":"Plasma aldosterone and its relationships with left ventricular mass in essential hypertensive patients with metabolic syndrome","volume":"21","author":"Mul\u00e8","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ccl.2010.04.001_bib45","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jc.2008-0251","article-title":"Body moss index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients","volume":"93","author":"Rossi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ccl.2010.04.001_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198104163041602","article-title":"The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients","volume":"304","author":"Tuck","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2010.04.001_bib47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.numecd.2008.06.001","article-title":"Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity","volume":"19","author":"Dall'Asta","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ccl.2010.04.001_bib49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1468-1293.2007.00537.x","article-title":"Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000\u20132006","volume":"9","author":"Nguyen","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.ccl.2010.04.001_bib50","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1097\/QAD.0b013e3283328d3b","article-title":"Increased aldosterone among HIV-infected women with visceral fat accumulation","volume":"23","author":"Lo","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ccl.2010.04.001_bib51","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-1406","article-title":"Familial and phenotypic associations of the aldosterone renin ratio","volume":"94","author":"Alvarez-Madrazo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ccl.2010.04.001_bib52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ccl.2010.04.001_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension","volume":"55","author":"de Souza","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/psc.1174","article-title":"Local formation of angiotensin peptides with paracrine activity by adipocytes","volume":"15","author":"Weiland","year":"2009","journal-title":"J Pept Sci"},{"key":"10.1016\/j.ccl.2010.04.001_bib55","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ccl.2010.04.001_bib56","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1357-2725(02)00311-4","article-title":"The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?","volume":"35","author":"Engeli","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ccl.2010.04.001_bib57","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1096\/fj.07-9412com","article-title":"A novel adipokine CTRP1 stimulates aldosterone production","volume":"22","author":"Jeon","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ccl.2010.04.001_bib58","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.HYP.0000113294.06704.64","article-title":"Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2010.04.001_bib59","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Ehrhart-Bornstein","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.ccl.2010.04.001_bib60","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.ijo.0803642","article-title":"Human adipocytes induce an ERK1\/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and angiotensin II-sensitization in human adrenocortical cells","volume":"31","author":"Krug","year":"2007","journal-title":"Int J Obes (Lond)"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386511000041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386511000041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T16:58:37Z","timestamp":1544374717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386511000041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S073386511000041X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2010.04.001","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}